@drocon
Just ignore those down ramper and troll.
Great works new BOD.
All the best new BOD and shares holders
I like the forecast for FY2024
FY24 Outlook The Company is committed to delivering growth for shareholders in FY24 including:
• Net sales revenue $80m, representing a 35% increase on the previous year
• Gross profit margin of 40%
• Continued FDA progress
• Renewed focus on infant & adult goat nutrition
• Working capital improvements
• Improved transparency and governance
• Cash flow positive in FY25.
Ann: Strategic Review - Presentation, page-5
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $120.4M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 14.5¢ | 13.0¢ | $435.1K | 3.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1920461 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 94096 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
-0.005 ( 6.05 %) |
||||
| Open | High | Low | Volume | ||
| 14.0¢ | 14.5¢ | 13.0¢ | 1825665 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| BUB (ASX) Chart |
